Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CREM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HOXB7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TNFRSF21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACAA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPMT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
H2AFV - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSMA7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTSB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NQO1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ID1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAB3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IFT27 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPA17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM57 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AAED1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC127 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on